# MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

> **NCT00003736** · NA · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 200 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** motexafin gadolinium
- **PROCEDURE:** biopsy
- **PROCEDURE:** breast imaging study
- **PROCEDURE:** comparison of screening methods
- **PROCEDURE:** magnetic resonance imaging
- **PROCEDURE:** study of high risk factors

## Key facts

- **NCT ID:** NCT00003736
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-06
- **Primary completion:** 2002-06
- **Final completion:** 2002-06
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003736, "MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00003736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*